🇺🇸 FDA
Pipeline program

Atorvastatin

09/2020

Unknown small_molecule completed

Quick answer

Atorvastatin for Contrast-induced Acute Kidney Injury is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Contrast-induced Acute Kidney Injury
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials